Friday, 4 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 23, 2026

Cardinal Health and FMC Corporation have been highlighted as Zacks Bull and Bear of the Day

View original at finance.yahoo.com
Cardinal Health and FMC Corporation have been highlighted as Zacks Bull and Bear of the Day For Immediate Release Chicago, IL – February 23, 2026 – Zacks Equity Research shares Cardinal Health CAH as the Bull of the Day and FMC Corporation FMC as the Bear of the Day…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Tariff charges and higher costs expected to impact FMC's margins

    80% confidence
  • JPMorgan aims to lift its share of U.S. retail deposits through branch density

    80% confidence
  • Weaker prices due to competition for key portfolio products expected to continue weighing on FMC sales

    80% confidence
  • Cardinal Health is a Zacks Rank #1 (Strong Buy) and expected to outperform the market

    80% confidence
  • Approximately half of a stock's price appreciation is due to its industry grouping, with top 50% of Zacks Ranked Industries outperforming bottom 50% by more than 2 to 1

    80% confidence
  • Cardinal Health expects specialty products to generate more than $50 billion in sales during current fiscal year

    80% confidence
  • Cardinal Health has delivered positive earnings surprises in each of the past 14 quarters with trailing four-quarter average surprise of over 9%

    80% confidence
  • FMC Corporation is a Zacks Rank #5 (Strong Sell) and expected to underperform

    80% confidence
  • JPMorgan plans to open more than 160 new branches across more than 30 U.S. states in 2026

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com